GuideAI Health (NEOE:GDAI) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NEOE:GDAI GuideAI Health Corp NEOE:GDAI
10 GF Score
Price C$1.25
View Full Analysis

What is GuideAI Health Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NEOE:GDAI
10GF Score
GuideAI Health Corp NEOE:GDAI
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GuideAI Health Business Description

Other Exchanges ZN0:Germany
Address 550 Burrard Street, Suite 2300, Vancouver, BC, CAN, V6C 2B5
GuideAI Health Corp is a healthcare technology company using artificial intelligence to enable the early detection of vascular disease and support more precise treatment decisions. Its platform analyzes routine CT scans to identify peripheral vascular disease and other vascular conditions that are frequently missed or under-reported, generating structured, actionable reports for radiologists and treating clinicians. By surfacing disease earlier and matching findings to appropriate treatment pathways, it aims to improve patient outcomes while helping hospitals and radiology groups deliver more comprehensive vascular care. Its Platform Capabilities are AI-powered vascular imaging, Early detection of disease, subtle patterns and risk signals, Structured, consistent AI-generated, and Others.
10GF Score

Get the complete analysis for NEOE:GDAI

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.25
Price